Concepedia

Keith M. Hamel

KM

Statistics

Publications

15

Citations

1.3K

H-Index

14

Active since

1991

Affiliations

Rush University Medical Center(Current)

University of Chicago

Center for Rheumatology

Czech Academy of Sciences, Institute of Microbiology

AbbVie (United States)

Keith M. Hamel is an author at Rush University Medical Center specializing in immunology, life sciences, and autoimmunity.

ORCID

Publications per year

1991–2023

15

Publications

15

Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2

Malay Mandal, Sarah E. Powers, Mark Maienschein‐Cline et al. · Nature Immunology · 2011 · 188 citations · Full text

, , +13

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 174 citations · Full text

, , +17

Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade

Frederick J. Kohlhapp, Dipica Haribhai, Rebecca Mathew et al. · Cancer Discovery · 2020 · 129 citations · Full text

, , +17

Expression of CD80/86 on B Cells Is Essential for Autoreactive T Cell Activation and the Development of Arthritis

Shannon O’Neill, Yanxia Cao, Keith M. Hamel et al. · The Journal of Immunology · 2007 · 127 citations · Full text

, , +17

B cells expressing IFN‐γ suppress Treg‐cell differentiation and promote autoimmune experimental arthritis

Susan Olalekan, Yanxia Cao, Keith M. Hamel et al. · European Journal of Immunology · 2015 · 103 citations · Full text

, , +17

1–5 of 15